Compulsory patent licensing and access to medicines: a silver bullet approach to public health?
"This book focuses on the ability of countries to provide essential medicines to their populations even when these medicines are patented. It provides an analysis of current global intellectual property flexibilities and case studies from several developing countries including India and Brazil....
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cham, Switzerland
Palgrave Macmillan
[2022]
|
| Schlagworte: | |
| Zusammenfassung: | "This book focuses on the ability of countries to provide essential medicines to their populations even when these medicines are patented. It provides an analysis of current global intellectual property flexibilities and case studies from several developing countries including India and Brazil. It also provides policy recommendations which many developing counties could consider while designing their national intellectual property protection regimes. This monograph focuses on India and Brazil's use of compulsory licensing, one of the most significant and controversial TRIPS flexibilities. The author studies historical developments and political conditions of the patent system and compulsory licensing from the earliest stage to the modern arena, with a great emphasis on TRIPS. After conducting a cross-national study of India and Brazil, the book moves on to evaluate the different philosophies on compulsory licensing of multilateral organizations such as the EU, the WIPO, the WTO, and NGOs"--Publisher's description |
| Beschreibung: | xiii, 184 Seiten Diagramme 22 cm |
| ISBN: | 9783030841928 3030841928 9783030841959 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047912701 | ||
| 003 | DE-604 | ||
| 005 | 20230307 | ||
| 007 | t | ||
| 008 | 220405s2022 |||| b||| 00||| eng d | ||
| 020 | |a 9783030841928 |c hbk |9 978-3-030-84192-8 | ||
| 020 | |a 3030841928 |9 3-030-84192-8 | ||
| 020 | |a 9783030841959 |c pbk |9 978-3-030-84195-9 | ||
| 035 | |a (OCoLC)1372480137 | ||
| 035 | |a (DE-599)BVBBV047912701 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-19 | ||
| 100 | 1 | |a Le, Van Anh |e Verfasser |0 (DE-588)1257910965 |4 aut | |
| 245 | 1 | 0 | |a Compulsory patent licensing and access to medicines |b a silver bullet approach to public health? |c Van Anh Le |
| 264 | 1 | |a Cham, Switzerland |b Palgrave Macmillan |c [2022] | |
| 300 | |a xiii, 184 Seiten |b Diagramme |c 22 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 505 | 8 | |a An Introduction to the Debate on Patents and Access to Medicines -- International Patent Law and the Pharmaceutical Industry -- The Development of Compulsory Licensing within International Patent Law -- The Indian Case Study of Compulsory Licensing -- The Brazilian Case Study of Compulsory Licensing -- Access to Medicines and Multilateral Organisations | |
| 520 | 3 | |a "This book focuses on the ability of countries to provide essential medicines to their populations even when these medicines are patented. It provides an analysis of current global intellectual property flexibilities and case studies from several developing countries including India and Brazil. It also provides policy recommendations which many developing counties could consider while designing their national intellectual property protection regimes. This monograph focuses on India and Brazil's use of compulsory licensing, one of the most significant and controversial TRIPS flexibilities. The author studies historical developments and political conditions of the patent system and compulsory licensing from the earliest stage to the modern arena, with a great emphasis on TRIPS. After conducting a cross-national study of India and Brazil, the book moves on to evaluate the different philosophies on compulsory licensing of multilateral organizations such as the EU, the WIPO, the WTO, and NGOs"--Publisher's description | |
| 648 | 7 | |a Geschichte |2 gnd |9 rswk-swf | |
| 650 | 0 | 7 | |a Arzneimittelimport |0 (DE-588)4233054-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lizenzpolitik |0 (DE-588)4167984-2 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Brasilien |0 (DE-588)4008003-1 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Indien |0 (DE-588)4026722-2 |2 gnd |9 rswk-swf | |
| 653 | 0 | |a Drugs / Patents | |
| 653 | 0 | |a Compulsory licensing of patents | |
| 653 | 0 | |a Drug accessibility / Law and legislation | |
| 653 | 0 | |a Compulsory licensing of patents | |
| 653 | 0 | |a Drug accessibility / Law and legislation | |
| 653 | 0 | |a Drugs | |
| 653 | 6 | |a Patents | |
| 689 | 0 | 0 | |a Indien |0 (DE-588)4026722-2 |D g |
| 689 | 0 | 1 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | 2 | |a Arzneimittelimport |0 (DE-588)4233054-3 |D s |
| 689 | 0 | 3 | |a Lizenzpolitik |0 (DE-588)4167984-2 |D s |
| 689 | 0 | 4 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |D s |
| 689 | 0 | 5 | |a Brasilien |0 (DE-588)4008003-1 |D g |
| 689 | 0 | 6 | |a Geschichte |A z |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-030-84193-5 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033294420 | ||
Datensatz im Suchindex
| _version_ | 1804183531851612160 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Le, Van Anh |
| author_GND | (DE-588)1257910965 |
| author_facet | Le, Van Anh |
| author_role | aut |
| author_sort | Le, Van Anh |
| author_variant | v a l va val |
| building | Verbundindex |
| bvnumber | BV047912701 |
| contents | An Introduction to the Debate on Patents and Access to Medicines -- International Patent Law and the Pharmaceutical Industry -- The Development of Compulsory Licensing within International Patent Law -- The Indian Case Study of Compulsory Licensing -- The Brazilian Case Study of Compulsory Licensing -- Access to Medicines and Multilateral Organisations |
| ctrlnum | (OCoLC)1372480137 (DE-599)BVBBV047912701 |
| era | Geschichte gnd |
| era_facet | Geschichte |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03504nam a2200577 c 4500</leader><controlfield tag="001">BV047912701</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230307 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220405s2022 |||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030841928</subfield><subfield code="c">hbk</subfield><subfield code="9">978-3-030-84192-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3030841928</subfield><subfield code="9">3-030-84192-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030841959</subfield><subfield code="c">pbk</subfield><subfield code="9">978-3-030-84195-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1372480137</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047912701</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Le, Van Anh</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1257910965</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Compulsory patent licensing and access to medicines</subfield><subfield code="b">a silver bullet approach to public health?</subfield><subfield code="c">Van Anh Le</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham, Switzerland</subfield><subfield code="b">Palgrave Macmillan</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiii, 184 Seiten</subfield><subfield code="b">Diagramme</subfield><subfield code="c">22 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">An Introduction to the Debate on Patents and Access to Medicines -- International Patent Law and the Pharmaceutical Industry -- The Development of Compulsory Licensing within International Patent Law -- The Indian Case Study of Compulsory Licensing -- The Brazilian Case Study of Compulsory Licensing -- Access to Medicines and Multilateral Organisations</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"This book focuses on the ability of countries to provide essential medicines to their populations even when these medicines are patented. It provides an analysis of current global intellectual property flexibilities and case studies from several developing countries including India and Brazil. It also provides policy recommendations which many developing counties could consider while designing their national intellectual property protection regimes. This monograph focuses on India and Brazil's use of compulsory licensing, one of the most significant and controversial TRIPS flexibilities. The author studies historical developments and political conditions of the patent system and compulsory licensing from the earliest stage to the modern arena, with a great emphasis on TRIPS. After conducting a cross-national study of India and Brazil, the book moves on to evaluate the different philosophies on compulsory licensing of multilateral organizations such as the EU, the WIPO, the WTO, and NGOs"--Publisher's description</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelimport</subfield><subfield code="0">(DE-588)4233054-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lizenzpolitik</subfield><subfield code="0">(DE-588)4167984-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Brasilien</subfield><subfield code="0">(DE-588)4008003-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Indien</subfield><subfield code="0">(DE-588)4026722-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Patents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Compulsory licensing of patents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug accessibility / Law and legislation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Compulsory licensing of patents</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug accessibility / Law and legislation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">Patents</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Indien</subfield><subfield code="0">(DE-588)4026722-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelimport</subfield><subfield code="0">(DE-588)4233054-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Lizenzpolitik</subfield><subfield code="0">(DE-588)4167984-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Brasilien</subfield><subfield code="0">(DE-588)4008003-1</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="6"><subfield code="a">Geschichte</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-030-84193-5</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033294420</subfield></datafield></record></collection> |
| geographic | Brasilien (DE-588)4008003-1 gnd Indien (DE-588)4026722-2 gnd |
| geographic_facet | Brasilien Indien |
| id | DE-604.BV047912701 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T19:31:46Z |
| indexdate | 2024-07-10T09:24:56Z |
| institution | BVB |
| isbn | 9783030841928 3030841928 9783030841959 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033294420 |
| oclc_num | 1372480137 |
| open_access_boolean | |
| owner | DE-M382 DE-19 DE-BY-UBM |
| owner_facet | DE-M382 DE-19 DE-BY-UBM |
| physical | xiii, 184 Seiten Diagramme 22 cm |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Palgrave Macmillan |
| record_format | marc |
| spelling | Le, Van Anh Verfasser (DE-588)1257910965 aut Compulsory patent licensing and access to medicines a silver bullet approach to public health? Van Anh Le Cham, Switzerland Palgrave Macmillan [2022] xiii, 184 Seiten Diagramme 22 cm txt rdacontent n rdamedia nc rdacarrier An Introduction to the Debate on Patents and Access to Medicines -- International Patent Law and the Pharmaceutical Industry -- The Development of Compulsory Licensing within International Patent Law -- The Indian Case Study of Compulsory Licensing -- The Brazilian Case Study of Compulsory Licensing -- Access to Medicines and Multilateral Organisations "This book focuses on the ability of countries to provide essential medicines to their populations even when these medicines are patented. It provides an analysis of current global intellectual property flexibilities and case studies from several developing countries including India and Brazil. It also provides policy recommendations which many developing counties could consider while designing their national intellectual property protection regimes. This monograph focuses on India and Brazil's use of compulsory licensing, one of the most significant and controversial TRIPS flexibilities. The author studies historical developments and political conditions of the patent system and compulsory licensing from the earliest stage to the modern arena, with a great emphasis on TRIPS. After conducting a cross-national study of India and Brazil, the book moves on to evaluate the different philosophies on compulsory licensing of multilateral organizations such as the EU, the WIPO, the WTO, and NGOs"--Publisher's description Geschichte gnd rswk-swf Arzneimittelimport (DE-588)4233054-3 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Internationaler Vergleich (DE-588)4120509-1 gnd rswk-swf Lizenzpolitik (DE-588)4167984-2 gnd rswk-swf Brasilien (DE-588)4008003-1 gnd rswk-swf Indien (DE-588)4026722-2 gnd rswk-swf Drugs / Patents Compulsory licensing of patents Drug accessibility / Law and legislation Drugs Patents Indien (DE-588)4026722-2 g Gesundheitspolitik (DE-588)4113743-7 s Arzneimittelimport (DE-588)4233054-3 s Lizenzpolitik (DE-588)4167984-2 s Internationaler Vergleich (DE-588)4120509-1 s Brasilien (DE-588)4008003-1 g Geschichte z DE-604 Erscheint auch als Online-Ausgabe 978-3-030-84193-5 |
| spellingShingle | Le, Van Anh Compulsory patent licensing and access to medicines a silver bullet approach to public health? An Introduction to the Debate on Patents and Access to Medicines -- International Patent Law and the Pharmaceutical Industry -- The Development of Compulsory Licensing within International Patent Law -- The Indian Case Study of Compulsory Licensing -- The Brazilian Case Study of Compulsory Licensing -- Access to Medicines and Multilateral Organisations Arzneimittelimport (DE-588)4233054-3 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Internationaler Vergleich (DE-588)4120509-1 gnd Lizenzpolitik (DE-588)4167984-2 gnd |
| subject_GND | (DE-588)4233054-3 (DE-588)4113743-7 (DE-588)4120509-1 (DE-588)4167984-2 (DE-588)4008003-1 (DE-588)4026722-2 |
| title | Compulsory patent licensing and access to medicines a silver bullet approach to public health? |
| title_auth | Compulsory patent licensing and access to medicines a silver bullet approach to public health? |
| title_exact_search | Compulsory patent licensing and access to medicines a silver bullet approach to public health? |
| title_exact_search_txtP | Compulsory patent licensing and access to medicines a silver bullet approach to public health? |
| title_full | Compulsory patent licensing and access to medicines a silver bullet approach to public health? Van Anh Le |
| title_fullStr | Compulsory patent licensing and access to medicines a silver bullet approach to public health? Van Anh Le |
| title_full_unstemmed | Compulsory patent licensing and access to medicines a silver bullet approach to public health? Van Anh Le |
| title_short | Compulsory patent licensing and access to medicines |
| title_sort | compulsory patent licensing and access to medicines a silver bullet approach to public health |
| title_sub | a silver bullet approach to public health? |
| topic | Arzneimittelimport (DE-588)4233054-3 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Internationaler Vergleich (DE-588)4120509-1 gnd Lizenzpolitik (DE-588)4167984-2 gnd |
| topic_facet | Arzneimittelimport Gesundheitspolitik Internationaler Vergleich Lizenzpolitik Brasilien Indien |
| work_keys_str_mv | AT levananh compulsorypatentlicensingandaccesstomedicinesasilverbulletapproachtopublichealth |